Globus Medical, Inc. (GMED)

Globus Medical Financials Overview

Financials in millions USD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	3,145	2,939	2,519	1,568	1,023	958.1
Revenue Growth	19.74%	16.65%	60.62%	53.34%	6.76%	21.43%
Gross Profit Gross Profit Growth	2,169	2,001	1,699	1,092	760.01	718.88
Operating Income Operating Income Growth	730.32	600.27	441.03	273.51	237.15	194.86
Net Income Net Income Growth	535.43	537.87	102.98	122.87	190.17	149.19
Earnings Per Share EPS Growth	3.91	3.92	0.75	1.07	1.85	1.44
EPS Growth	51.94%	422.67%	-29.91%	-42.16%	28.47%	42.57%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Musculoskeletal Solutions Musculoskeletal Solutions Growth	3,008	2,798	2,365	1,448	926.7	876.78
Enabling Technologies Enabling Technologies Growth	136.6	141.01	154	120.22	96.14	81.32
Revenue (Total) Revenue (Total) Growth	3,145	2,939	2,519	1,568	1,023	958.1

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	840.5	629.06	956.19	593.22	941.91	1,006
Total Debt Total Debt Growth	111.91	119.44	537.72	521.22	6.01	-
Net Cash (Debt) Net Cash Growth	728.59	509.62	418.47	72	935.9	1,006
Net Cash Growth	574.39%	21.78%	481.20%	-92.31%	-6.96%	28.89%
Net Cash Per Share Net Cash Per Share Growth	5.32	3.72	3.04	0.63	9.12	9.71

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	910.39	753.45	520.64	243.5	178.47	276.27
Capital Expenditures CapEx Growth	-154.8	-164.68	-115.43	-78.27	-74.05	-56.9
Free Cash Flow Free Cash Flow Growth	755.59	588.77	405.21	165.23	104.42	219.38
Free Cash Flow Growth	43.26%	45.30%	145.25%	58.23%	-52.40%	62.34%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	68.97%	68.07%	67.46%	69.62%	74.30%	75.03%
Operating Margin	23.22%	20.42%	17.51%	17.44%	23.18%	20.34%
Pretax Margin	20.99%	20.59%	4.79%	10.54%	23.76%	18.83%
Profit Margin	17.03%	18.30%	4.09%	7.83%	18.59%	15.57%
FCF Margin	24.03%	20.03%	16.08%	10.53%	10.21%	22.90%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	22.59	21.73	109.36	59.76	38.99	49.11
Forward PE	17.33	21.59	25.54	20.76	32.74	33.48
P/FCF Ratio	15.70	19.85	27.79	44.44	71.01	33.40
PS Ratio	3.77	3.98	4.47	4.68	7.25	7.65

Data Sources: S&P Global Market Intelligence and Fiscal.ai Last updated: Aug 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company. Revenue segment data is provided by Fiscal.ai.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error